Editing Adjuvant and Salvage Radiotherapy After Prostatectomy (2019) (section)

== Definitions ==

* '''<span style="color:#ff0000">Adjuvant radiotherapy (ART): administration of radiotherapy (RT) to post-radical prostatectomy (RP) patients at a higher risk of recurrence because of adverse pathological features prior to evidence of disease recurrence (i.e., with an undetectable PSA)</span>'''
* '''<span style="color:#ff0000">Salvage radiotherapy (SRT): administration of RT to post-RP patients with PSA recurrence after surgery but no evidence of distant metastatic disease</span>'''
** '''<span style="color:#ff0000">Biochemical recurrence after surgery is defined as a detectable PSA level > 0.2 ng/mL with a second confirmatory level > 0.2 ng/mL.</span>'''
**'''<span style="color:#ff0000">Radiation for persistent post-prostatectomy PSA after RP is considered salvage[https://uroweb.org/guidelines/prostate-cancer/chapter/treatment], not adjuvant</span>'''
***'''<span style="color:#ff0000">Patients with adverse pathology detected at prostatectomy who have a persistent post-prostatectomy PSA level should be offered post-RP SRT</span>'''